↓ Skip to main content

An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis

Overview of attention for article published in Respirology, June 2011
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis
Published in
Respirology, June 2011
DOI 10.1111/j.1440-1843.2011.01955.x
Pubmed ID
Authors

MONIQUE A. MALOUF, PETER HOPKINS, GREGORY SNELL, ALLAN R. GLANVILLE

Abstract

We evaluated the efficacy and safety of everolimus, a macrocyclic proliferation signal inhibitor with anti-fibroproliferative activity to prevent disease progression or death in patients with IPF, a progressive, fatal disease with no known effective therapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 13%
Student > Master 6 12%
Student > Doctoral Student 5 10%
Other 5 10%
Researcher 5 10%
Other 8 15%
Unknown 16 31%
Readers by discipline Count As %
Medicine and Dentistry 13 25%
Agricultural and Biological Sciences 5 10%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 5 10%
Unknown 21 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2023.
All research outputs
#16,721,208
of 25,373,627 outputs
Outputs from Respirology
#2,133
of 2,962 outputs
Outputs of similar age
#91,678
of 127,289 outputs
Outputs of similar age from Respirology
#12
of 18 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,962 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,289 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.